According to Zevra Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.94. In 2022 the company made an earnings per share (EPS) of -$1.20 an increase over its 2021 EPS that were of -$2.89.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.94 | -21.67% |
2022 | -$1.20 | -58.48% |
2021 | -$2.89 | -17.9% |
2020 | -$3.52 | -74.91% |
2019 | -$14.03 | -72.43% |
2018 | -$50.88 | 7.8% |
2017 | -$47.20 | 143.8% |
2016 | -$19.36 | -71.57% |
2015 | -$68.09 | 65.3% |
2014 | -$41.19 |